Blade Air Mobility, Inc. is a high-risk transportation company in the United States that operates a technology-powered air mobility platform. Specializing in air transportation and logistics for hospitals and the transportation of human organs for transplant, Blade Air Mobility provides services via helicopters and fixed-wing aircraft in the Northeast United States, Southern Europe, and Western Canada. With operating segments focusing on Passenger and Medical services, Blade Air Mobility generates a majority of its revenue from the Medical segment. In addition to organ transportation, the company offers donor logistics coordination and support services. The company's strong presence in the United States contributes significantly to its revenue stream. Blade Air Mobility's ESG score is 39.8.